McCarthy Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-130,363
Closed -$8.94M 38
2024
Q2
$8.94M Buy
130,363
+42
+0% +$2.8K 5.27% 7
2024
Q1
$9.55M Sell
130,321
-1,252
-1% -$96.3K 5.88% 5
2023
Q4
$10.7M Buy
131,573
+2
+0% +$156 6.82% 5
2023
Q3
$9.86M Sell
131,571
-965
-0.7% -$74.2K 7.23% 4
2023
Q2
$10.2M Sell
132,536
-252
-0.2% -$20.1K 6.96% 4
2023
Q1
$11M Sell
132,788
-229
-0.2% -$19K 7.48% 4
2022
Q4
$11.4M Sell
133,017
-16,967
-11% -$1.34M 7.97% 4
2022
Q3
$9.25M Sell
149,984
-467
-0.3% -$29.4K 7.24% 4
2022
Q2
$9.3M Buy
150,451
+2
+0% +$124 7.57% 4
2022
Q1
$8.94M Buy
150,449
+2
+0% +$128 6.23% 4
2021
Q4
$10.9M Sell
150,447
-1,415
-0.9% -$97.5K 7.51% 4
2021
Q3
$10.6M Sell
151,862
-2,440
-2% -$171K 7.97% 4
2021
Q2
$10.6M Sell
154,302
-9,532
-6% -$636K 7.56% 4
2021
Q1
$10.6M Sell
163,834
-8,603
-5% -$555K 8.28% 4
2020
Q4
$10M Buy
+172,437
New +$10.4M 8.33% 4

Other funds holding GILD

McCarthy Asset Management's GILD Position: Q3 2024 in Review

McCarthy Asset Management sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 130,363 shares — an estimated $8.94M sold.

McCarthy Asset Management first reported a position in GILD in Q4 2020 and held it in 15 quarters. The position peaked at $11.4M in Q4 2022. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • McCarthy Asset Management reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • McCarthy Asset Management sold 130,363 Gilead Sciences shares in Q3 2024, an estimated $8.94M.
  • McCarthy Asset Management first reported a position in Gilead Sciences in Q4 2020 and held it in 15 quarters.
  • McCarthy Asset Management's Gilead Sciences position peaked at $11.4M in Q4 2022.
  • 1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on McCarthy Asset Management's 13F filing for Q3 2024, filed 18 Nov 2024.